USCIS Policy
O-1A Original Contributions: IRB-Confidential Human Subjects Research
Researchers whose primary work involves human subjects data often cannot publish findings in time to satisfy the O-1A original contributions criterion. This guide explains how AAO decisions and USCIS policy treat IRB-restricted research records and what petitioners can submit as evidence.
The criterion and what is at stake for human subjects researchers
Researchers whose primary body of work involves human subjects data face an evidentiary challenge that runs directly through the original contributions criterion. The O-1A standard under 8 C.F.R. § 214.2(o)(3)(iii)(A)(5) requires that the petitioner show original contributions of major significance in the field. For clinical researchers, social scientists, and public health investigators working under Institutional Review Board protocols, the full data underlying research findings is often unpublishable during an IRB restriction period, restricted from secondary use, or stripped of identifying information to a degree that limits the public evidentiary value of the underlying record.
The AAO has addressed the original contributions criterion in several precedent and non-precedent decisions that clarify how the criterion applies across research contexts. These decisions collectively establish that the petitioner must show not only that research was conducted but that it produced findings of major significance that were recognized by others in the field. This framework is achievable even when underlying data is confidential, but it requires a deliberate approach to evidence construction that accounts for the IRB constraint at every step.
The consequence of an inadequate showing on this criterion is not always outright denial — an O-1A petitioner must satisfy at least three of the eight criteria, and a strong record on other criteria can offset a thin original contributions showing. But for researchers in fields where scholarly publication is the primary criterion as well, a failure on both original contributions and scholarly articles often leaves a petition short of the three-criterion threshold. Understanding how to build an IRB-compliant original contributions record is essential for researchers in clinical, social science, and public health disciplines.
What the regulation requires
8 C.F.R. § 214.2(o)(3)(iii)(A)(5) provides that original scientific, scholarly, or business-related contributions of major significance in the field satisfy the criterion. USCIS adjudication practice, as reflected in AAO decisions, treats this criterion as requiring a two-part showing: originality and major significance. Original means that the contribution represents the petitioner's own creative work, not a replication or routine application of others' methods. Major significance means that the contribution meaningfully advanced the field — other researchers built on it, clinical practice changed as a result, or policymakers adopted recommendations derived from it.
Significance in the research context is not equivalent to impact factor or citation count, though both are relevant evidence. USCIS has accepted expert testimony explaining significance in terms that go beyond bibliometric measurements — including testimony that a finding changed the research agenda of a subfield, that it resolved a contested methodological debate, or that it was adopted in clinical guidelines or public health recommendations. For human subjects researchers, the path to demonstrating major significance often runs through downstream adoption of findings rather than through the data itself, which means the evidentiary record can be built without disclosing protected participant information.
USCIS does not require that the evidence itself contain the underlying data. What is required is evidence of the contribution and its impact. A peer-reviewed publication that reports findings derived from human subjects data, without disclosing protected data, constitutes evidence of an original contribution. A clinical guideline that cites the petitioner's research as foundational constitutes evidence of major significance. The IRB restriction runs to the underlying data, not to the publication of findings derived from that data — which means the evidentiary path for most human subjects researchers is through publication and adoption rather than through submission of the IRB-restricted research record.
Evidence that routinely satisfies the criterion
Published peer-reviewed articles reporting findings from IRB-approved human subjects research are the primary evidence category and remain available even for restricted datasets, because publication of aggregate findings under IRB protocol is the standard research dissemination pathway. High-quality publications in top journals in the petitioner's field — clinical medicine, social science, public health — that report original research findings satisfy the originality component. Citation records, systematic review inclusions, and meta-analyses that draw on the petitioner's published findings satisfy the major significance component by showing that other researchers built their own work on the petitioner's findings.
Adoption of research findings in clinical practice guidelines is among the strongest evidence of major significance. When the petitioner's research has been incorporated into clinical guidelines issued by major medical societies or public health recommendations issued by federal agencies, the petitioner can submit those guidelines with an annotation identifying the specific study that was cited or adopted. This evidence is compelling because it shows that recognized experts in the field — guideline development committees — specifically evaluated the research and determined it was significant enough to incorporate into practice standards that affect patient care.
Expert letters from senior researchers in the petitioner's subfield who can specifically explain the significance of the contribution are essential supporting evidence. These letters should address what methodological problem the petitioner's research solved, what findings were novel and why they were not predictable from prior work, and how the field's research agenda or clinical practice changed as a direct result of the petitioner's contribution. Letters that merely describe the petitioner as a leading researcher without explaining why the specific contribution was of major significance to the field do not satisfy the criterion's evidentiary requirements.
Evidence USCIS regularly discounts
Research that was conducted under IRB protocols but remains entirely unpublished at the time of filing presents a near-insurmountable evidentiary challenge under the original contributions criterion. USCIS requires evidence of the contribution and its impact; a study that is ongoing or whose findings have not yet been disseminated has not yet demonstrated major significance, regardless of its expected future impact. Researchers filing O-1A petitions should ideally wait until at least the primary findings from major projects have been published before relying on those projects as original contributions evidence.
Internal research reports — studies completed for a hospital system, a government agency, or a private company that have not been peer-reviewed or publicly released — are typically discounted unless they are accompanied by strong evidence that the report itself was treated as significant by its commissioning authority and was acted upon in a meaningful way. An internal report that led to a policy change within an organization may support an original contributions argument through expert testimony and documentation of the policy change, but the report itself, without that corroborating evidence, is weak evidence of major significance in the broader field.
Manuscripts under review are also regularly discounted as original contributions evidence, because USCIS evaluates petitions on the record as it stands at the time of filing. A manuscript submitted for peer review but not yet accepted does not establish either that the contribution is original or that it is significant. Where a manuscript is under review and the petitioner needs to rely on that work as original contributions evidence, the petition should include available evidence of significance — pre-publication citations, conference presentations at major venues, or expert letters from researchers in adjacent subfields who have encountered the work.
How to present borderline evidence
For researchers whose primary original contributions evidence is a thin publication record supplemented by significant but undisclosable work, the expert letter strategy requires particular care. The letter writer must be able to explain, without disclosing the underlying data, why the petitioner's research produced findings of major significance to the field. This is achievable when the letter writer can speak to the research design's sophistication, the methodological advances the petitioner introduced, or the novelty of the population studied — none of which requires disclosure of participant-level data.
A useful framing technique for borderline cases is the counterfactual argument: had the petitioner's research not been conducted, what would the field not know, and at what cost to patients, policymakers, or future researchers? When the record supports a concrete answer — a specific gap in knowledge that the petitioner's work filled — the expert letter can make this argument explicitly. This is particularly effective when the research addressed a population or methodological challenge that other researchers had avoided, and the petitioner's willingness to work within the IRB framework was itself evidence of the research's rigor.
Where the petitioner has testified before government bodies, provided expert consultation to federal agencies, or served on scientific advisory panels in connection with their human subjects research program, those activities can be presented as evidence of recognition flowing from the original contributions, even if the underlying research remains partially confidential. An invitation to testify before a Congressional subcommittee on the petitioner's area of human subjects expertise, or a formal consultation with a federal advisory committee, documents that recognized authorities have identified the petitioner's research as significant enough to draw on — without disclosure of the underlying data.
Building and auditing the file
Before filing, map every claimed original contribution to at least two independent pieces of evidence: one documenting the contribution itself and one documenting its major significance. Contributions supported by only one evidence item are vulnerable to the adjudicator concluding that the significance has not been established. Where a second item is unavailable, a strong expert letter that specifically explains why this particular contribution was of major significance — not just what it showed — can serve as the second item.
Pay particular attention to the distinction between the petitioner's role in a multi-investigator project and the contribution claimed in the petition. Human subjects research is frequently team science, and a petitioner who was one of many investigators on a large clinical trial cannot claim the entire trial's impact as their original contribution without evidence establishing their specific intellectual role. Expert letters should describe what conceptual or methodological contribution this petitioner specifically made — what would not have happened the same way if someone of equal seniority but different expertise had filled the petitioner's role.
The overall petition structure matters. An O-1A petition for a human subjects researcher that satisfies the scholarly articles, judging, and critical role criteria with strong evidence may be approved even if the original contributions criterion is the weakest element in the record. If the record clearly shows that the petitioner has published at a high level, has been invited to judge others' work, and holds a critical role at a distinguished institution, the totality of evidence may reflect extraordinary ability even without the strongest possible original contributions showing. Audit each criterion independently, then assess whether the combination is persuasive.
What we typically gather for this kind of case
| Document | Where to source | Why it matters |
|---|---|---|
| Peer-reviewed publications | Web of Science / Scopus exports | Anchors original-contributions and authorship criteria |
| Citation analysis | Google Scholar profile + ESI top-1% data | Quantifies major significance in the field |
| Salary benchmark | BLS OEWS for SOC code + locality | Documents high-salary criterion at 90th-percentile or above |
| Critical-role letters | Direct supervisor + program director | Establishes role's importance, not just title |
What we see go wrong, again and again
- 01Treating extraordinary ability as a credentials checklist rather than a story of field-wide impact.
- 02Submitting bibliometric data (h-index, citation counts) without explaining what makes those numbers high relative to peers in the same sub-field.
- 03Relying on letters from collaborators or co-authors rather than independent experts who can speak to influence.
See if you qualify
Lando reviews your background against the O-1 visa criteria and tells you honestly where you stand. Free, no commitment.